WHO Launches Prequalification Program For Insulin In Effort To Drive Down Prices, Expand Access

New York Times: To Drive Down Insulin Prices, WHO Will Certify Generic Versions
“With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health Organization said on Wednesday that it would begin testing and approving generic versions of the drug. … The approval process, which the WHO calls ‘prequalification,’ will permit United Nations agencies and medical charities like Doctors Without Borders to buy approved generic versions of insulin. The process also will reassure countries without strong regulatory agencies that the approved drugs are safe for their health ministries to purchase. The WHO aims to duplicate its success in widening global access to HIV drugs…” (McNeil, 11/13).

Additional coverage of the WHO’s plan is available from U.N. News, VOA and Xinhua.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.